Haemonetics HAE Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's total liabilities & equity?
- Haemonetics (HAE) reported total liabilities & equity of $2.4B in Q1 2026.
- How has Haemonetics's total liabilities & equity changed year-over-year?
- Haemonetics's total liabilities & equity decreased by 2.2% year-over-year, from $2.45B to $2.4B.
- What is the long-term trend for Haemonetics's total liabilities & equity?
- Over 5 years (2021 to 2026), Haemonetics's total liabilities & equity has grown at a 5.7% compound annual growth rate (CAGR), from $1.82B to $2.4B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.